Screening for congenital heart disease: A move toward earlier echocardiography

American Journal of Perinatology

Volumn 24, Issue 8, 2007, Pages 449-456

  Johnson, Blair ^a,b   Simpson, Lynn L ^a  

^a New York Presbyterian Morgan Stanley Children's Hospital   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Congenital heart disease; Fetal echocardiography; Fetal heart; Nuchal translucency; Prenatal diagnosis

Indexed keywords

ARTICLE; CONGENITAL HEART DISEASE; CYSTIC LYMPHANGIOMA; DIAGNOSTIC ACCURACY; EARLY DIAGNOSIS; ECHOCARDIOGRAPHY; FAMILY HISTORY; FETUS; FETUS HEART; FIRST TRIMESTER PREGNANCY; HUMAN; MAJOR CLINICAL STUDY; NUCHAL TRANSLUCENCY MEASUREMENT; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

EARLY DIAGNOSIS; ECHOCARDIOGRAPHY; FEMALE; FETAL HEART; HEART DEFECTS, CONGENITAL; HUMANS; MASS SCREENING; PREGNANCY; RISK FACTORS; ULTRASONOGRAPHY, PRENATAL;

EID: 35148849073     PISSN: 07351631     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-986681     Document Type: Article

References (56)

1. Buskens E, Steyerberg EW, Hess J, Wladimiroff JW, Grobbee DE. Routine prenatal screening for congenital heart disease: what can be expected? A decision-analytic approach. Am J Public Health 1997;87:962-967
2. Hoffman JI, Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol 2002;39:1890-1900
3. Montana E, Khoury MJ, Cragan JD, Sharma S, Dhar P, Fyfe D. Trends and outcomes after prenatal diagnosis of congenital cardiac malformations by fetal echocardiography in a well defined birth population, Atlanta, Georgia, 1990-1993. J Am Coll Cardiol 1996;28:1805-1809
4. Abu-Harb M, Hey E, Wren C. Death in infancy from unrecognized congenital heart disease. Arch Dis Child 1994;71:3-7
5. Hoffman JI, Christian R. Congenital heart disease in a cohort of 19,502 births with long-term follow up. Am J Cardiol 1978;42:641-647
6. Crawford DC, Chita SK, Allan LD. Prenatal detection of congenital heart disease: factors affecting obstetric management and survival. Am J Obstet Gynecol 1988;159:352-356
7. Sharland GK, Lockhart SM, Chita SK, Allan LD. Factors influencing the outcome of congenital heart disease detected prenatally. Arch Dis Child 1991;66:284-287
8. Vergani P, Mariani S, Ghidini A, et al. Screening for congenital heart disease with four-chamber view of the fetal heart. Am J Obstet Gynecol 1992;167:1000-1003
9. Davis GK, Farquhar CM, Allan LD, Crawford DC, Chapman MG. Structural cardiac abnormalities in the fetus: reliability of prenatal diagnosis and outcome. Br J Obstet Gynaecol 1990;97:27-31
10. Smythe JF, Copel JA, Kleinman CS. Outcome of prenatally detected cardiac malformations. Am J Cardiol 1992;69:1471-1474
11. Bonnet D, Coltri A, Butera G, et al. Detection of transposition of the great arteries in fetuses reduces neonatal morbidity and mortality. Circulation 1999;99:916-918
12. Chang AC, Huhta JC, Yoon GY, et al. Diagnosis, transport and outcome of fetuses with left ventricular outflow tract obstruction. J Thorac Cardiovasc Surg 1991;102:841-848
13. Cheitlein MD, Alpert JS, Armstrong WF, et al. ACC/AHA Guidelines for the clinical application of echocardiography. J Am Coll Cardiol 1997;95:1686-1744
14. Allan LD. Fetal echocardiography. Clin Obstet Gynecol 1988;31:61-79
15. Small M, Copel JA. Indications for fetal echocardiography. Pediatr Cardiol 2004;25:210-222
16. Wapner R, Thom E, Simpson JL, et al. First trimester maternal serum biochemistry and fetal nuchal translucency screening (BUN) study group. N Engl J Med 2003;349:1405-1413
17. Malone FD, Canick JA, Ball RH, et al. First-trimester or second-trimester screening, or both, for Down's syndrome. N Engl J Med 2005;353:2001-2011
18. Nicolaides KH, Spencer K, Avqidou K, Faiola S, Falcon O. Multicenter study of first-trimester screening for trisomy 21 in 75,821 pregnancies: results and estimation of the potential impact of individual risk-orientated two-stage first-trimester screening. Ultrasound Obstet Gynecol 2005;25:221-226
19. Cleary-Goldman J, Morgan MA, Malone FD, Robinson JN, D'Alton ME, Schulkin J. Screening for Down's syndrome: practice patterns and knowledge of obstetricians and gynecologists. Obstet Gynecol 2006;107:11-17
20. Hyett J, Moscoso G, Papapanagiotu G, Perdu M, Nicolaides K. Abnormalities of the heart and great arteries in chromosomally normal fetuses with increased nuchal translucency thickness at 11-13 weeks gestation. Ultrasound Obstet Gynecol 1996;7:245-250
21. Hyett JA, Perdu M, Sarland GK, Snijders RJM, Nicolaides KH. Increased nuchal translucency at 10-14 weeks of gestation as a marker for major cardiac defects. Ultrasound Obstet Gynecol 1997;10:242-246
22. Mavrides E, Cobian-Sanchez F, Tekay A, et al. Limitations of using first-trimester nuchal translucency measurement in routine screening for major congenital heart defects. Ultrasound Obstet Gynecol 2001;17(2):106-110
23. Zosmer N, Souter VL, Chan CSY, Huggon I, Nicolaides K. Early diagnosis of major cardiac defects in chromosomally normal fetuses with increased nuchal translucency. Br J Obstet Gynaecol 1999;106:829-833
24. Schwarzler P, Carvalho JS, Senat MV, Masroor T, Campbell S, Ville Y. Screening for fetal aneuploidies and fetal cardiac abnormalities by nuchal translucency thickness measurement at 10-14 weeks of gestation as part of routine antenatal care in an unselected population. Br J Obstet Gynaecol 1999;106:1029-1034
25. Michailidis GD, Economides DL. Nuchal translucency measurement and pregnancy outcome in karyotypically normal fetuses. Ultrasound Obstet Gynecol 2001;17:102-105
26. Simpson LL, Malone FD, Bianchi DW, et al. Nuchal translucency and the risk of congenital heart disease. Obstet Gynecol 2007;109:376-383
27. Bahado-Singh RO, Wapner R, Thom E, et al. Elevated first-trimester nuchal translucency increases the risk of congenital heart defects. Am J Obstet Gynecol 2005;192:1357-1361
28. Malone FD, Ball RH, Nyberg DA, et al. First-trimester septated cystic hygroma: prevalence, natural history and pediatric outcome. Obstet Gynecol 2005;106:288-294
29. Manning N, Archer N. A study to determine the incidence of structural congenital heart disease in monochorionic twins. Prenat Diagn 2006;26:1062-1064
30. Harkness UF, Crombleholme TM. Twin-twin transfusion syndrome: where do we go from here? Semin Perinatol 2005;29:296-304
31. 2003: Assisted Reproductive Technology Success Rates. Published in 2005 by Centers for Disease Control. Available online at: www.cdc.gov/ART/ART2003. Accessed 9/3/07
32. Hansen M, Bower C, Milne E, de Klerk N, Kurinczuk JJ. Assisted reproductive technologies and the risks of birth defects - a systematic review. Hum Reprod 2005;20:329-333
33. SSRI antidepressants and birth defects. Prescrire Int 2006;15:222-223
34. Kulin NA, Pastuszak A, Sage SR, et al. Pregnancy outcome following maternal use of the new selective serotonin reuptake inhibitors: a prospective controlled multicenter study. JAMA 1998;279:609-610
35. Wogelius P, Norgaard M, Gislum M, et al. Maternal use of selective serotonin reuptake inhibitors and risk of congenital malformations. Epidemiology 2006;17:701-704
36. Thormahlen GM. Paroxetine use during pregnancy: is it safe? Ann Pharmacother 2006;40:1834-1837
37. U.S. Food and Drug Administration: FDA public health advisory: paroxetine, 12/8/05. Available at: www.fda.gov/cder/drug/advisory/ paroxetine200512.htm. Accessed May 7, 2007
38. Bérard A, Ramos É, Rey É, Biais L, St.-André , Oraichi D. First trimester exposure to paroxetine and risk of cardiac malformations in infants: the importance of dosage. Birth Defects Res B Dev Reprod Toxical 2007;80:18-27
39. Kapusta L, Haagmans MLM, Steegers EAP, Cuypers MHM, Blom HJ, Eskes TKAB. Congenital heart defects and maternal derangement of homocysteine metabolism. J Pediatr 1999;135:773-774
40. Wenstrom KD, Johanning GL, Johnston KE, DuBard M. Association of the C677T methylenetetrahydrofolate reductase mutation and elevated homocysteine levels with congenital cardiac malformations. Am J Obstet Gynecol 2001;184:806-817
41. Junker R, Kotthoff S, Vielhaber H, et al. Infant methylenetetrahydrofolate reductase 677T genotype is a risk factor for congenital heart disease. Cardiovasc Res 2001;51:251-254
42. American Society of Echocardiography. Guidelines and standards for performance of the fetal echocardiogram. J Am Soc Echocardiogr 2004;17:803-810
43. Allan L. Technique of fetal echocardiography. Pediatr Cardiol 2004;25:223-233
44. Simpson J. Echocardiographic evaluation of cardiac function in the fetus. Prenat Diagn 2004;24:1081-1091
45. Haak MC, Twisk JWR, Van Vugt JMG. How successful is fetal echocardiographic examination in the first trimester of pregnancy? Ultrasound Obstet Gynecol 2002;20:9-13
46. Souka AP, Pilaris A, Kavalakis Y, Kosmas Y, Antsaklis P, Antsaklis A. Assessment of fetal anatomy at the 11-14 week ultrasound examination. Ultrasound Obstet Gynecol 2004;24:730-734
47. Vimpelli T, Huhtala H, Acharya G. Fetal echocardiography during routine first-trimester screening: a feasibility study in an unselected population. Prenat Diagn 2006;26:475-482
48. Smrcek JM, Berg C, Geipel A, Fimmers R, Diedrich K, Gembruch U. Early fetal echocardiography: Heart biometry and visualization of cardiac structures between 10 and 15 weeks' gestation. J Ultrasound Med 2006;25:173-182
49. Becker R, Wegner RD. Detailed screening for fetal anomalies and cardiac defects at the 11-13 week scan. Ultrasound Obstet Gynecol 2006;27:613-618
50. Carvalho JS, Moscoso G, Tekay A, Campbell S, Thiloganatham B, Shinebourne EA. Clinical impact of first and early second trimester fetal echocardiography on high risk pregnancies. Heart 2004;90:921-926
51. Gabriel CC, Galindo A, Martinez JM, et al. Early prenatal diagnosis of major cardiac anomalies in a high risk population screening. Prenat Diagn 2002;22:586-593
52. Gembruch U, Knopfle G, Bald R, Hansmann M. Early diagnosis of fetal congenital heart disease by transvaginal echocardiography. Ultrasound Obstet Gynecol 1993;3:310-317
53. Huggon IC, Ghi T, Cook AC, Zosmer N, Allan LD, Nicolaides KH. Fetal cardiac abnormalities identified prior to 14 weeks' gestation. Ultrasound Obstet Gynecol 2002;20:22-29
54. McAuliffe FM, Trines J, Nield LE, Chitayat D, Jaeggi E, Hornberger LK. Early fetal echocardiography - a reliable prenatal diagnosis tool. Am J Obstet Gynecol 2005;193:1253-1259
55. Smrcek JM, Berg C, Geipel A, et al. Detection rate of early fetal echocardiography and in utero development of congenital heart defect. J Ultrasound Med 2006;25:187-196
56. Weiner Z, Lorber A, Shalev E. Diagnosis of congenital cardiac defects between 11 and 14 weeks' gestation in high-risk patients. J Ultrasound Med 2002;21:23-29